Cargando…
Thrombocytopenia and its association with mortality in patients with COVID‐19
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes novel coronavirus disease 2019 (COVID‐19), is spreading rapidly around the world. Thrombocytopenia in patients with COVID‐19 has not been fully studied. OBJECTIVE: To describe thrombocytopenia in patients with COV...
Autores principales: | Yang, Xiaobo, Yang, Qingyu, Wang, Yaxin, Wu, Yongran, Xu, Jiqian, Yu, Yuan, Shang, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906135/ https://www.ncbi.nlm.nih.gov/pubmed/32302435 http://dx.doi.org/10.1111/jth.14848 |
Ejemplares similares
-
Plasma metabolomic and lipidomic alterations associated with COVID-19
por: Wu, Di, et al.
Publicado: (2020) -
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
por: Xu, Jiqian, et al.
Publicado: (2020) -
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
por: Yang, Xiaobo, et al.
Publicado: (2020) -
Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study
por: Tang, Yun, et al.
Publicado: (2023) -
Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19
por: Qiu, Yang, et al.
Publicado: (2021)